BioNTech SE (BNTX)
USD 97.37
(-1.91%)
USD 97.37
(-1.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.08 Billion EUR | -91.18% |
| 2022 | 12.42 Billion EUR | -12.52% |
| 2021 | 15 Billion EUR | 35652.26% |
| 2020 | -105.1 Million EUR | 71.19% |
| 2019 | -152.3 Million EUR | -387.11% |
| 2018 | -30 Million EUR | 38.44% |
| 2017 | -48.74 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -652.88 Million EUR | -159.21% |
| 2024 Q1 | -288.8 Million EUR | -163.39% |
| 2023 Q4 | 507.4 Million EUR | 135.23% |
| 2023 FY | - EUR | -91.18% |
| 2023 Q3 | 215.7 Million EUR | 156.91% |
| 2023 Q2 | -379 Million EUR | -145.09% |
| 2023 Q1 | 840.6 Million EUR | -74.99% |
| 2022 FY | - EUR | -12.52% |
| 2022 Q3 | 2.26 Billion EUR | 15.6% |
| 2022 Q2 | 1.95 Billion EUR | -58.54% |
| 2022 Q1 | 4.72 Billion EUR | 2.98% |
| 2022 Q4 | 3.36 Billion EUR | 48.56% |
| 2021 Q2 | 4.17 Billion EUR | 155.84% |
| 2021 FY | - EUR | 35652.26% |
| 2021 Q1 | 1.63 Billion EUR | 740.19% |
| 2021 Q4 | 4.58 Billion EUR | 0.14% |
| 2021 Q3 | 4.57 Billion EUR | 9.63% |
| 2020 FY | - EUR | 71.19% |
| 2020 Q4 | 194.27 Million EUR | 209.69% |
| 2020 Q3 | -177.1 Million EUR | -146.2% |
| 2020 Q1 | -44.26 Million EUR | 8.74% |
| 2020 Q2 | -71.93 Million EUR | -62.51% |
| 2019 Q3 | -21.08 Million EUR | 45.97% |
| 2019 Q2 | -39.03 Million EUR | -18.02% |
| 2019 Q1 | -33.07 Million EUR | -560.55% |
| 2019 FY | - EUR | -387.11% |
| 2019 Q4 | -48.5 Million EUR | -130.03% |
| 2018 Q1 | -10.52 Million EUR | 0.0% |
| 2018 Q4 | 7.18 Million EUR | 144.05% |
| 2018 FY | - EUR | 38.44% |
| 2018 Q3 | -16.3 Million EUR | -54.85% |
| 2018 Q2 | -10.52 Million EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Allakos Inc. | -189.91 Million USD | 672.677% |
| Compugen Ltd. | -12.51 Million USD | 8789.677% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | 2185.603% |
| Abeona Therapeutics Inc. | -50.57 Million USD | 2250.597% |
| Akero Therapeutics, Inc. | -148.63 Million USD | 831.745% |
| Alzamend Neuro, Inc. | -9.88 Million USD | 11100.409% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | 4600.538% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 578.205% |
| 180 Life Sciences Corp. | -22.13 Million USD | 5013.701% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | 3954.141% |
| Eterna Therapeutics Inc. | -19.93 Million USD | 5556.005% |
| Calithera Biosciences, Inc. | -38.26 Million USD | 2942.284% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | 1141.214% |
| Clearmind Medicine Inc. | -8.71 Million USD | 12585.847% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | 1963.222% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | -904.025% |
| CorMedix Inc. | -48.88 Million USD | 2324.721% |
| CRISPR Therapeutics AG | -202.7 Million USD | 636.554% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | 25340.195% |
| Daré Bioscience, Inc. | -30.7 Million USD | 3642.496% |
| Dyadic International, Inc. | -8.22 Million USD | 13315.486% |
| 89bio, Inc. | -134.46 Million USD | 908.847% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | 1281.16% |
| Heron Therapeutics, Inc. | -103.79 Million USD | 1147.865% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 626.191% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | 15496.526% |
| Kodiak Sciences Inc. | -259.02 Million USD | 519.885% |
| Keros Therapeutics, Inc. | -152.17 Million USD | 814.694% |
| Kura Oncology, Inc. | -164.95 Million USD | 759.331% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | 859.492% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 386.234% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | 2041.415% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | 1737.582% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | -48562.192% |
| Organovo Holdings, Inc. | -14.8 Million USD | 7445.671% |
| Ovid Therapeutics Inc. | -58.71 Million USD | 1952.395% |
| Arbutus Biopharma Corporation | -70.98 Million USD | 1632.133% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | 1703.491% |
| Neurogene Inc. | -52.28 Million USD | 2180.098% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | 4168.228% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | 3910.391% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | 674.62% |
| Agenus Inc. | -145.92 Million USD | 845.319% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 2220.326% |
| Alector, Inc. | -142.89 Million USD | 861.134% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | 1397.62% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | 1174.544% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 1394.993% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 319.624% |
| Aptorum Group Limited | -9.59 Million USD | 11430.35% |
| Aptose Biosciences Inc. | -52.26 Million USD | 2180.814% |
| Ardelyx, Inc. | -55.35 Million USD | 2064.808% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | 10328.534% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | 783.814% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | 4878.139% |
| Purple Biotech Ltd. | -22.22 Million USD | 4993.588% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | 113659.122% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | 719.108% |
| Atai Life Sciences N.V. | -36.31 Million USD | 3095.236% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 508.877% |
| Autolus Therapeutics plc | -156.77 Million USD | 793.755% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | -18557.641% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 559.636% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 292.336% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | 1034.886% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | 15935.76% |
| Akari Therapeutics, Plc | -16.8 Million USD | 6573.039% |
| Alkermes plc | 495.04 Million USD | -119.695% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | 7065.99% |
| bluebird bio, Inc. | -167.16 Million USD | 750.63% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | -250.518% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | 13609.765% |
| Annexon, Inc. | -141.57 Million USD | 868.215% |
| Apollomics, Inc. | -171.74 Million USD | 733.257% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | 6151.148% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | 3786.03% |
| Blueprint Medicines Corporation | -474.61 Million USD | 329.156% |
| Artelo Biosciences, Inc. | -10.28 Million USD | 10674.623% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | 1553.722% |
| Roivant Sciences Ltd. | -996.51 Million USD | 209.14% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | 757.474% |
| Sesen Bio, Inc. | -50.84 Million USD | 2239.26% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 71175.63% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 474.213% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 463.059% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | -205495.463% |
| Better Therapeutics, Inc. | -38.26 Million USD | 2942.507% |
| Synaptogenix, Inc. | -8.3 Million USD | 13191.774% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | 1562.968% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | 2357.649% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | 7000.577% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | 7324.159% |
| CalciMedica, Inc. | -34.18 Million USD | 3281.14% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | 5149.445% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | 4563.78% |
| Celularity Inc. | -183.94 Million USD | 691.26% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | 791.88% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | 17881.277% |
| TScan Therapeutics, Inc. | -80.09 Million USD | 1457.837% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | 13320.897% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 27290.367% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | 1053.291% |
| Cullinan Oncology, Inc. | -190.33 Million USD | 671.402% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | 2062.044% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | 987.793% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | 882.255% |
| Clene Inc. | -43.24 Million USD | 2615.205% |
| Clearside Biomedical, Inc. | -23.05 Million USD | 4816.801% |
| Chimerix, Inc. | -92.97 Million USD | 1269.789% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | 754.92% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | 5714.289% |
| ContextLogic Inc. | -324 Million USD | 435.679% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | 2547.526% |
| Caribou Biosciences, Inc. | -112.53 Million USD | 1066.463% |
| Cardiff Oncology, Inc. | -45.01 Million USD | 2516.137% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | 1269.236% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | 15279.344% |
| GeoVax Labs, Inc. | -26.66 Million USD | 4178.178% |
| Gritstone bio, Inc. | -126.86 Million USD | 957.303% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | 710258.081% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | 4378.184% |
| Vera Therapeutics, Inc. | -102.01 Million USD | 1166.149% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | 5561.925% |
| INmune Bio, Inc. | - USD | -Infinity% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | 3451.308% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 1773.617% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 5495.109% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | 13053.788% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | 5732.898% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | 24184.779% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | 4336.522% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | 15074.504% |
| Zai Lab Limited | -366.57 Million USD | 396.694% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | 1109.436% |
| Precision BioSciences, Inc. | -32.04 Million USD | 3494.295% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 565.829% |
| Elevation Oncology, Inc. | -41.46 Million USD | 2722.808% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | 3358.922% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | 3399.157% |
| Enveric Biosciences, Inc. | -17.13 Million USD | 6445.397% |
| Seres Therapeutics, Inc. | -85.43 Million USD | 1373.029% |
| Evogene Ltd. | -23.2 Million USD | 4787.123% |
| BioLineRx Ltd. | -57.06 Million USD | 2006.03% |
| Exelixis, Inc. | 196.6 Million USD | -453.199% |
| Eyenovia, Inc. | -24.1 Million USD | 4611.733% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | 1676.209% |
| Fate Therapeutics, Inc. | -172.22 Million USD | 731.485% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | 2013.273% |
| Fortress Biotech, Inc. | -133.64 Million USD | 913.81% |
| Fortress Biotech, Inc. | -133.64 Million USD | 913.81% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | 6939.821% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 583.397% |
| C4 Therapeutics, Inc. | -122.1 Million USD | 990.723% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | 1115.329% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 44647.955% |
| FibroGen, Inc. | -261.4 Million USD | 516.059% |
| Gain Therapeutics, Inc. | -22.16 Million USD | 5005.827% |
| Generation Bio Co. | -133.3 Million USD | 915.904% |
| Genelux Corporation | -24.16 Million USD | 4600.724% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | 1506.204% |
| Humacyte, Inc. | -96.45 Million USD | 1227.537% |
| ImmunityBio, Inc. | -436.18 Million USD | 349.345% |
| ImmuCell Corporation | -2.5 Million USD | 43533.169% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 9862.14% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | 933.915% |
| IGM Biosciences, Inc. | -253.35 Million USD | 529.274% |
| Immunocore Holdings plc | -59.64 Million USD | 1923.333% |
| Immunovant, Inc. | -269.97 Million USD | 502.848% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 7194.166% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | 934.106% |
| Ainos, Inc. | -8.77 Million USD | 12496.989% |
| Korro Bio, Inc. | -80.9 Million USD | 1444.309% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | 10883.264% |
| Innoviva, Inc. | 248.96 Million USD | -336.857% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 572.849% |
| Jaguar Health, Inc. | -33.13 Million USD | 3382.726% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 1773.617% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | 4858.696% |
| BioAtla, Inc. | -122.24 Million USD | 989.718% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | 2724.074% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | 1195.774% |
| Benitec Biopharma Inc. | -22.49 Million USD | 4935.927% |
| Opthea Limited | -200.01 Million USD | 643.749% |
| Cabaletta Bio, Inc. | -73.23 Million USD | 1585.103% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | -969.136% |
| Avid Bioservices, Inc. | -11.48 Million USD | 9573.042% |
| Celularity Inc. | -183.94 Million USD | 691.26% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | 19783.116% |
| Arcellx, Inc. | -64.14 Million USD | 1795.534% |
| Mustang Bio, Inc. | -48.06 Million USD | 2362.863% |
| MiMedx Group, Inc. | 40.51 Million USD | -2584.305% |
| Applied Therapeutics, Inc. | -64.53 Million USD | 1785.287% |
| MacroGenics, Inc. | 2.01 Million USD | -53821.666% |
| MediciNova, Inc. | -9.87 Million USD | 11108.131% |
| Marker Therapeutics, Inc. | -11.79 Million USD | 9322.989% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | 754.865% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | -52.665% |
| Pyxis Oncology, Inc. | -78.49 Million USD | 1485.601% |
| Nutriband Inc. | -5.12 Million USD | 21334.818% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 565.788% |
| NextCure, Inc. | -59.03 Million USD | 1942.172% |
| Summit Therapeutics Inc. | 1 Million USD | -108551.349% |
| Omeros Corporation | -163.61 Million USD | 764.752% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | 373845.704% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 521.155% |
| Shattuck Labs, Inc. | -87.61 Million USD | 1341.34% |
| BeiGene, Ltd. | -1.12 Billion USD | 196.709% |
| Bionomics Limited | -9.83 Million USD | 11156.222% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | 2343.538% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | 5343.782% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | 787.363% |
| ChromaDex Corporation | -3.89 Million USD | 28030.149% |
| Pluri Inc. | -20.22 Million USD | 5477.503% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 44647.955% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | 6206.791% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | 1102.47% |
| Coherus BioSciences, Inc. | -193.93 Million USD | 660.795% |
| ESSA Pharma Inc. | -26.45 Million USD | 4211.084% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | 963.579% |
| Viking Therapeutics, Inc. | -100.82 Million USD | 1178.679% |
| Prime Medicine, Inc. | -193.75 Million USD | 661.316% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 429.237% |
| PolyPid Ltd. | -20.26 Million USD | 5467.418% |
| Quantum-Si incorporated | -91.8 Million USD | 1284.698% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 76.632% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | 11764.204% |
| Rallybio Corporation | -72.37 Million USD | 1602.77% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 352.588% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 4610.636% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 2952.106% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 530.92% |
| Cassava Sciences, Inc. | -95.68 Million USD | 1236.623% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | 1344.009% |
| Fortrea Holdings Inc. | 167.3 Million USD | -550.09% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 24.963% |
| Acelyrin, Inc. | -381.52 Million USD | 385.066% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 572.989% |
| Soligenix, Inc. | -7.85 Million USD | 13949.749% |
| SciSparc Ltd. | -5.28 Million USD | 20690.685% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 301.434% |
| Statera Biopharma, Inc. | 38.93 Million USD | -2693.377% |
| Protara Therapeutics, Inc. | -43.27 Million USD | 2613.404% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | 14677.134% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | 926.004% |
| Theravance Biopharma, Inc. | -40.86 Million USD | 2761.316% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | 15898.954% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | 3619.286% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | 1163.501% |
| TG Therapeutics, Inc. | 26.1 Million USD | -4067.05% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | 7190.423% |
| Trevena, Inc. | -35.28 Million USD | 3182.068% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -33913214.624% |
| Verastem, Inc. | -83.16 Million USD | 1407.746% |
| VYNE Therapeutics Inc. | -29.25 Million USD | 3817.274% |
| LAVA Therapeutics N.V. | -40.41 Million USD | 2790.947% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | 1115.471% |
| Xencor, Inc. | -125.87 Million USD | 964.039% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | 142456.021% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 494.769% |
| Mesoblast Limited | -61.33 Million USD | 1873.328% |
| Molecular Templates, Inc. | 1.43 Million USD | -75955.944% |
| Incyte Corporation | 919.42 Million USD | -18.291% |
| PDS Biotechnology Corporation | -40.08 Million USD | 2813.236% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | 2016.341% |
| Moleculin Biotech, Inc. | -29.5 Million USD | 3786.28% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 314.807% |
| Onconetix, Inc. | -36.7 Million USD | 3062.945% |
| Precigen, Inc. | -89.22 Million USD | 1318.927% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | -720623.109% |
| XOMA Corporation | -39.36 Million USD | 2863.071% |
| Pulmatrix, Inc. | -12.64 Million USD | 8700.348% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 390.683% |
| Scholar Rock Holding Corporation | -168.45 Million USD | 745.648% |
| Surrozen, Inc. | -41.13 Million USD | 2744.234% |
| Seer, Inc. | -97.88 Million USD | 1211.1% |
| Unity Biotechnology, Inc. | -37.28 Million USD | 3017.147% |
| Insmed Incorporated | -654.73 Million USD | 266.112% |
| Century Therapeutics, Inc. | -121.2 Million USD | 997.301% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | 1848.637% |
| Humacyte, Inc. | -96.45 Million USD | 1227.537% |
| Immunome, Inc. | -28.27 Million USD | 3947.052% |
| Immunic, Inc. | -99.11 Million USD | 1197.344% |
| Curis, Inc. | -45.13 Million USD | 2509.446% |
| Cytokinetics, Incorporated | -456.68 Million USD | 338.152% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 3242.808% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | 8066.015% |
| Entero Therapeutics, Inc. | -15.74 Million USD | 7008.361% |
| Erasca, Inc. | -121.31 Million USD | 996.546% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | 13623.495% |
| GRI Bio, Inc. | -10.89 Million USD | 10079.813% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | -253396.768% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | 2307.945% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | 5113.962% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | 6948.866% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 3722.315% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | 909.949% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | 4361.922% |
| PureTech Health plc | -11.62 Million USD | 9454.09% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 24275.572% |
| MeiraGTx Holdings plc | -57.05 Million USD | 2006.331% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | 964.231% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 310.59% |
| Royalty Pharma plc | 1.88 Billion USD | 42.372% |
| Solid Biosciences Inc. | -93.43 Million USD | 1264.03% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | 76340.147% |
| Cue Biopharma, Inc. | -46.05 Million USD | 2461.678% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | 9593.02% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | 1247.596% |
| ProKidney Corp. | -147.66 Million USD | 836.512% |
| Prothena Corporation plc | -190.1 Million USD | 672.096% |
| Structure Therapeutics Inc. | -102.45 Million USD | 1161.498% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | 8440994.722% |
| Tango Therapeutics, Inc. | -111.75 Million USD | 1073.174% |
| Turnstone Biologics Corp. | -56.23 Million USD | 2034.061% |
| 2seventy bio, Inc. | -206.41 Million USD | 626.892% |
| Vaxxinity, Inc. | -56.05 Thousand USD | 1940475.729% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 563.667% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | 3855.136% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | 2337.952% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | 869.117% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | -26741.066% |
| Cingulate Inc. | -22.95 Million USD | 4838.578% |
| MediWound Ltd. | -4.89 Million USD | 22327.672% |
| Senti Biosciences, Inc. | -61.33 Million USD | 1873.184% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | 1437.548% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 15634.196% |
| Assembly Biosciences, Inc. | -64.19 Million USD | 1794.187% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | 1009.418% |
| Carmell Therapeutics Corporation | -15.19 Million USD | 7259.433% |
| Genprex, Inc. | -31.06 Million USD | 3601.546% |
| IO Biotech, Inc. | -91.22 Million USD | 1292.178% |
| OmniAb, Inc. | -49.73 Million USD | 2286.966% |
| Regulus Therapeutics Inc. | -30.88 Million USD | 3621.793% |
| Veracyte, Inc. | -49.4 Million USD | 2301.218% |
| Vor Biopharma Inc. | -114.37 Million USD | 1050.94% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 623.297% |
| NLS Pharmaceutics AG | -11.79 Million USD | 9320.344% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 462.18% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | 1825.062% |
| Cara Therapeutics, Inc. | -117.65 Million USD | 1024.437% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 22798.69% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | 980.819% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 17124.008% |
| UroGen Pharma Ltd. | -63.83 Million USD | 1803.874% |
| Sutro Biopharma, Inc. | -67.91 Million USD | 1701.414% |
| Entera Bio Ltd. | -8.8 Million USD | 12453.476% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | -439839.163% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | 4682.262% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | 1068.443% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | 1384.714% |
| Novavax, Inc. | -487.39 Million USD | 323.148% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | 1422.583% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | 48443.815% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | 1995.568% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | 2420.857% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | 4383.239% |
| Histogen Inc. | -10.5 Million USD | 10455.137% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | 7716.402% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 17124.008% |
| Portage Biotech Inc. | -18.19 Million USD | 6076.153% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 71175.63% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 582.843% |
| OncoCyte Corporation | -23.12 Million USD | 4803.542% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | 9724.47% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | 13143.888% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | -2626.498% |
| Amarin Corporation plc | -50.9 Million USD | 2236.674% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | 3941.616% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | 679.973% |
| NLS Pharmaceutics AG | -11.79 Million USD | 9320.344% |
| Savara Inc. | -59.13 Million USD | 1939.244% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 562.683% |
| Bicycle Therapeutics plc | -183.4 Million USD | 693.021% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | 6771.901% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | 1303.896% |
| Aura Biosciences, Inc. | -83.69 Million USD | 1399.465% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | 5910.802% |
| Scopus BioPharma Inc. | -11.71 Million USD | 9385.291% |
| Galecto, Inc. | -37.51 Million USD | 2998.798% |
| XBiotech Inc. | -35.76 Million USD | 3140.877% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | 1766.82% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | 948.375% |
| NexImmune, Inc. | -28.16 Million USD | 3961.186% |
| Imunon, Inc. | -19.87 Million USD | 5571.299% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 628.32% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | 11010.915% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 433.368% |
| GT Biopharma, Inc. | 5.97 Million USD | -18090.333% |
| Adagene Inc. | -14.95 Million USD | 7374.534% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | 966.634% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | -760.069% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | 1329.385% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 1142440.98% |
| Astria Therapeutics, Inc. | -83.03 Million USD | 1409.888% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | 1364.313% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | 11826.401% |
| Psyence Biomedical Ltd. | -2.75 Million USD | 39626.381% |
| Galectin Therapeutics Inc. | -202 Thousand USD | 538515.842% |
| ADMA Biologics, Inc. | 5.12 Million USD | -21142.188% |
| Renovaro Biosciences Inc. | -79.51 Million USD | 1467.758% |
| Sagimet Biosciences Inc. | -30.74 Million USD | 3638.061% |
| Biomea Fusion, Inc. | -124.62 Million USD | 972.733% |
| Capricor Therapeutics, Inc. | -23 Million USD | 4826.851% |
| Mereo BioPharma Group plc | -26.05 Million USD | 4274.087% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | 3061.12% |
| Absci Corporation | -95.45 Million USD | 1239.361% |
| aTyr Pharma, Inc. | -52.17 Million USD | 2184.403% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | 786.599% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -576246.274% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | -140.648% |
| Acasti Pharma Inc. | -11.3 Million USD | 9723.927% |
| Orgenesis Inc. | -60.71 Million USD | 1891.232% |
| Spruce Biosciences, Inc. | -47.36 Million USD | 2396.162% |
| GH Research PLC | -41.15 Million USD | 2742.821% |
| Tyra Biosciences, Inc. | -79.59 Million USD | 1466.469% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | -22049.562% |
| Replimune Group, Inc. | -230.19 Million USD | 572.463% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | 5495.479% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | 10039.682% |
| Kronos Bio, Inc. | -121.83 Million USD | 992.719% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | 338916.199% |
| MEI Pharma, Inc. | 26.38 Million USD | -4022.82% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | 1139.93% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | 17067.239% |
| scPharmaceuticals Inc. | -46.06 Million USD | 2461.217% |
| HilleVax, Inc. | -132.46 Million USD | 921.041% |
| Tharimmune, Inc. | -9.3 Million USD | 11791.369% |
| AlloVir, Inc. | -190.14 Million USD | 671.982% |
| Kineta, Inc. | -15.71 Million USD | 7021.217% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | 3568.776% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | -1152.822% |
| OKYO Pharma Limited | -15.74 Thousand USD | 6907308.049% |
| Codexis, Inc. | -49.28 Million USD | 2306.846% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 590.994% |
| Cibus, Inc. | -314.58 Million USD | 445.725% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| DBV Technologies S.A. | -85.98 Million USD | 1364.916% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | 1065.906% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | 3990.538% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 24275.572% |
| Moderna, Inc. | -3.28 Billion USD | 133.128% |
| Peak Bio, Inc. | -1356.23 USD | 80192987.637% |
| Vincerx Pharma, Inc. | -42.6 Million USD | 2652.512% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | 19356.374% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | 3357.653% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | 2223.431% |
| Puma Biotechnology, Inc. | 44.78 Million USD | -2328.546% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | 1917.149% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | 893.353% |
| Wave Life Sciences Ltd. | -58.79 Million USD | 1949.974% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 335779.012% |
| Adicet Bio, Inc. | -136.53 Million USD | 896.572% |
| Moolec Science SA | -52.07 Million USD | 2188.505% |
| Aditxt, Inc. | -25.45 Million USD | 4372.141% |
| RenovoRx, Inc. | -11.39 Million USD | 9648.727% |
| Geron Corporation | -174.78 Million USD | 722.261% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 14978.05% |
| Quantum-Si incorporated | -91.8 Million USD | 1284.698% |
| GlycoMimetics, Inc. | -39.12 Million USD | 2880.022% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | 3317.751% |
| Notable Labs, Ltd. | -14.4 Million USD | 7652.778% |
| Liquidia Corporation | -70.05 Million USD | 1652.583% |
| Vericel Corporation | 2.86 Million USD | -37874.86% |
| Invivyd, Inc. | -196.61 Million USD | 653.162% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | 4987.378% |
| Vaxcyte, Inc. | -464.88 Million USD | 333.95% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | 6504.805% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | 3879.539% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | 3037.078% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | -4513.753% |
| PepGen Inc. | -83.58 Million USD | 1401.237% |
| United Therapeutics Corporation | 1.38 Billion USD | 21.575% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | 3448.316% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | 22892.543% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -33913214.624% |
| Silo Pharma, Inc. | -3.62 Million USD | 30092.714% |
| Belite Bio, Inc | -31.52 Million USD | 3549.523% |
| Pharming Group N.V. | 9.87 Million USD | -10911.441% |
| XOMA Corporation | -39.36 Million USD | 2863.071% |
| Spero Therapeutics, Inc. | 27.15 Million USD | -3905.303% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 4610.636% |
| AbCellera Biologics Inc. | -192.15 Million USD | 665.993% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 14978.05% |
| GeoVax Labs, Inc. | -26.66 Million USD | 4178.178% |
| Surrozen, Inc. | -41.13 Million USD | 2744.234% |
| Janux Therapeutics, Inc. | -71.02 Million USD | 1631.313% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 258.935% |
| Evaxion Biotech A/S | -21.4 Million USD | 5181.531% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 9862.14% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 599.658% |
| BioVie Inc. | -31.95 Million USD | 3504.047% |
| Virax Biolabs Group Limited | -6.6 Million USD | 16555.989% |
| Lantern Pharma Inc. | -15.78 Million USD | 6989.348% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | 3324.143% |
| Immix Biopharma, Inc. | -16.13 Million USD | 6840.357% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 548.859% |
| Celcuity Inc. | -58.3 Million USD | 1965.205% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | 2207.507% |
| IN8bio, Inc. | -28.5 Million USD | 3915.605% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | 765.345% |
| Instil Bio, Inc. | -146.12 Million USD | 844.31% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 7194.166% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 616.643% |
| Immuneering Corporation | -58.06 Million USD | 1973.209% |
| Verona Pharma plc | -52.46 Million USD | 2172.899% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 3242.808% |
| uniQure N.V. | -253.1 Million USD | 529.712% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | 1573.633% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | 939.82% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | 1478.891% |
| Plus Therapeutics, Inc. | -12.69 Million USD | 8668.502% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | 25568.68% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 4849.967% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | 1712.525% |
| Zura Bio Limited | -60.56 Million USD | 1895.816% |
| Forte Biosciences, Inc. | -32.47 Million USD | 3448.832% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 335779.012% |
| Compass Therapeutics, Inc. | -48.47 Million USD | 2343.723% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | 989.696% |
| Altimmune, Inc. | -87.93 Million USD | 1336.823% |
| Aadi Bioscience, Inc. | -65.36 Million USD | 1763.887% |
| Moolec Science SA | -52.07 Million USD | 2188.505% |
| Lumos Pharma, Inc. | -36.57 Million USD | 3074.022% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | 1247.596% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | 3910.391% |
| Nutriband Inc. | -5.12 Million USD | 21334.818% |
| argenx SE | -216.02 Million USD | 603.465% |
| Tourmaline Bio, Inc. | -45.37 Million USD | 2496.862% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | 896.835% |
| NeurAxis, Inc. | -6.66 Million USD | 16419.316% |
| CervoMed Inc. | -2.17 Million USD | 50176.57% |
| AnaptysBio, Inc. | -143.16 Million USD | 859.688% |
| Design Therapeutics, Inc. | -66.32 Million USD | 1739.804% |
| Leap Therapeutics, Inc. | -80.98 Million USD | 1442.932% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | 2981.06% |
| Achilles Therapeutics plc | -70.44 Million USD | 1643.965% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | 1090.998% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | 2251.533% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | 1766.13% |
| MoonLake Immunotherapeutics | -54.1 Million USD | 2109.982% |
| Palisade Bio, Inc. | -12.28 Million USD | 8955.956% |
| Beam Therapeutics Inc. | -156.47 Million USD | 795.072% |
| AEON Biopharma, Inc. | -48.36 Million USD | 2348.92% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | 1427.442% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | 8906.461% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 354.45% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | 1133.87% |
| Athira Pharma, Inc. | -116.7 Million USD | 1031.938% |
| Vaccinex, Inc. | -19.74 Million USD | 5607.393% |
| HCW Biologics Inc. | -23.57 Million USD | 4713.155% |
| XOMA Corporation | -39.36 Million USD | 2863.071% |
| Nektar Therapeutics | -243.1 Million USD | 547.375% |
| Arvinas, Inc. | -394.8 Million USD | 375.481% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -576246.274% |
| Merus N.V. | -149.2 Million USD | 828.92% |
| Omega Therapeutics, Inc. | -93.49 Million USD | 1263.333% |
| Quince Therapeutics, Inc. | -31.26 Million USD | 3579.207% |
| Rezolute, Inc. | -68.42 Million USD | 1689.524% |
| Clene Inc. | -43.24 Million USD | 2615.205% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 7152.176% |
| BeyondSpring Inc. | -21.54 Million USD | 5149.211% |
| Synlogic, Inc. | -55.16 Million USD | 2071.683% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | 9101.076% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | 10319.883% |
| Peak Bio, Inc. | -1356.23 USD | 80192987.637% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | 3450.069% |
| Krystal Biotech, Inc. | 17.9 Million USD | -5974.62% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | 1018.403% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 418.621% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | 23710.465% |
| MannKind Corporation | 15.12 Million USD | -7088.843% |
| Ikena Oncology, Inc. | -74.39 Million USD | 1561.887% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | 8736.544% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | -5250.519% |
| Gossamer Bio, Inc. | -172.15 Million USD | 731.767% |
| CohBar, Inc. | -12.06 Million USD | 9113.938% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | 4363.593% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 3722.315% |
| Legend Biotech Corporation | -477.87 Million USD | 327.592% |
| Mural Oncology plc | -192.72 Million USD | 664.342% |
| Biora Therapeutics, Inc. | -114.05 Million USD | 1053.583% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | 6836.338% |
| Disc Medicine, Inc. | -91.02 Million USD | 1294.837% |
| Champions Oncology, Inc. | -5.05 Million USD | 21619.588% |
| REGENXBIO Inc. | -239.46 Million USD | 554.181% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | 10247.239% |
| Anavex Life Sciences Corp. | -55.75 Million USD | 2050.642% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | 2905.387% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | 1064.133% |
| Vaxart, Inc. | -74.72 Million USD | 1555.509% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | 3189.045% |
| Cellectis S.A. | -98.09 Million USD | 1208.721% |
| Longeveron Inc. | -20.06 Million USD | 5521.735% |
| Repare Therapeutics Inc. | -114.27 Million USD | 1051.756% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 347.634% |
| Inozyme Pharma, Inc. | -74.81 Million USD | 1553.777% |
| Revolution Medicines, Inc. | -430.58 Million USD | 352.588% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | 17393.687% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | 3632.43% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | 1558.104% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | -22082.337% |
| Anixa Biosciences, Inc. | -10.96 Million USD | 10018.833% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 76.383% |
| Denali Therapeutics Inc. | -179.97 Million USD | 704.313% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 1142440.98% |
| Veru Inc. | -89.97 Million USD | 1308.772% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | 4146.432% |
| Cingulate Inc. | -22.95 Million USD | 4838.578% |
| Passage Bio, Inc. | -98.34 Million USD | 1205.948% |
| Context Therapeutics Inc. | -25.06 Million USD | 4439.885% |
| Exicure, Inc. | -15.53 Million USD | 7099.163% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 627.797% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | 3041.367% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | 18340.377% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | 745.598% |
| Nuvalent, Inc. | -149.49 Million USD | 827.531% |
| ABVC BioPharma, Inc. | -8.13 Million USD | 13473.641% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | 1366.212% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | 3703.95% |
| OmniAb, Inc. | -49.73 Million USD | 2286.966% |
| Anew Medical, Inc. | -1.3 Million USD | 83707.515% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | 8896.506% |
| Lipocine Inc. | -16.32 Million USD | 6763.127% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | 1731.318% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | 1563.736% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 2952.106% |
| G1 Therapeutics, Inc. | -39.01 Million USD | 2887.717% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | 5002.854% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 299.534% |
| Ocugen, Inc. | -64.82 Million USD | 1777.696% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | 1274.895% |
| Q32 Bio Inc. | -86.5 Million USD | 1357.312% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | 6525.238% |
| Alumis Inc. Common Stock | -156.89 Million USD | 793.225% |
| Equillium, Inc. | -12.13 Million USD | 9060.29% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | 1960.036% |
| Coya Therapeutics, Inc. | -7.9 Million USD | 13861.255% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | 5866.404% |
| Galera Therapeutics, Inc. | -46.69 Million USD | 2429.307% |
| Evelo Biosciences, Inc. | -106.34 Million USD | 1122.709% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | 6180.533% |
| Dominari Holdings Inc. | -22.44 Million USD | 4946.702% |
| Edesa Biotech, Inc. | -8.19 Million USD | 13379.379% |
| vTv Therapeutics Inc. | -25.41 Million USD | 4379.868% |
| Bio-Techne Corporation | 326.66 Million USD | -232.943% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 382.593% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | -402.613% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | 929.545% |
| Candel Therapeutics, Inc. | -37.43 Million USD | 3005.613% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 819.783% |
| Nkarta, Inc. | -120.48 Million USD | 1002.715% |
| BioCardia, Inc. | -11.56 Million USD | 9508.304% |
| Iterum Therapeutics plc | -34.58 Million USD | 3245.171% |